Japan Case Study: Sleep Apnea Hidden in Older Diabetic Patient

A study from Japan reveals how a life-threatening sleep disorder went undetected in an elderly Type 1 diabetes patient — and how a specialized breathing device may have saved his life. Published in BMC Geriatrics, this case report from Minami Osaka Hospital offers a cautionary tale that resonates deeply for older Americans managing diabetes and heart disease.

What Happened

An 82-year-old Japanese man with Type 1 diabetes arrived at the hospital vomiting after his wife was unable to administer his insulin — his home glucose meter simply displayed "HIGH," meaning his blood sugar had surpassed the device's measurable range (above approximately 600 mg/dL). Doctors diagnosed him with diabetic ketoacidosis (DKA), a medical emergency caused by severely elevated blood sugar and dangerous acid buildup.

After stabilizing him with intensive insulin therapy, the medical team noticed something troubling: the patient was excessively sleepy during the day and his heart monitor showed frequent irregular heartbeats called premature ventricular contractions (PVCs). Crucially, his cognitive decline meant he could not report typical sleep apnea symptoms like nighttime gasping or restlessness — his wife had become his sole caregiver.

The Hidden Diagnosis

Suspecting a sleep disorder, doctors performed a portable sleep study (polysomnography). Results confirmed Central Sleep Apnea (CSA) — a brain-based breathing disorder distinct from the more common obstructive sleep apnea. His apnea-hypopnea index (AHI) measured 37.6 events per hour, well above the diagnostic threshold of 5, placing him in the severe range. He also had heart failure with preserved ejection fraction (HFpEF), a type of heart failure where the heart pumps normally but the muscle is too stiff.

Doctors treated him with Adaptive Support Ventilation (ASV), a specialized breathing machine that adjusts airflow in real time based on the patient's breathing patterns. Follow-up sleep studies and heart monitoring confirmed his breathing episodes resolved and his dangerous heart rhythm abnormalities improved significantly.

Why This Matters for US Patients

This Japanese case highlights several urgent concerns for American diabetes patients and their caregivers:

• Cognitive decline masks symptoms: An estimated 6.7 million Americans have Alzheimer's or dementia, and diabetes roughly doubles that risk. Patients who cannot self-report symptoms are especially vulnerable to missed diagnoses like CSA.
• Sleep apnea worsens blood sugar control: The American Diabetes Association (ADA) recognizes sleep disorders as a significant factor in insulin resistance and poor glycemic management. The ADA recommends screening for sleep apnea in patients with difficult-to-control diabetes.
• Heart risks multiply: HFpEF affects nearly half of all US heart failure patients — approximately 3 million Americans. The combination of CSA, HFpEF, and diabetes dramatically increases cardiac risk.
• ASV remains under-studied in the US: While CPAP is the standard US treatment for sleep apnea, ASV may be more effective for CSA, particularly in heart failure patients. This Japanese case adds to growing evidence supporting further clinical trials.
• Caregiver awareness is critical: Family members should alert doctors to excessive daytime sleepiness, irregular breathing at night, or unexplained heart rhythm changes in older diabetic loved ones.

The Bottom Line

This Japanese research reminds US clinicians and patients that sleep disorders in elderly diabetics are both underdiagnosed and potentially dangerous. A simple sleep study could uncover a hidden condition driving irregular heartbeats, daytime exhaustion, and poor blood sugar control — all at once.

Original study: Hajika, Kawaguchi, Hamazaki. "Adaptive support ventilation as an effective treatment option for central sleep apnea in an older adult with heart failure with preserved ejection fraction: a case report." BMC Geriatrics (2022). PMID: 35033005. DOI: 10.1186/s12877-021-02743-4